· rebuilt nightly from public records
Signal Sheet
Iambic Therapeutics is a listed biotechnology company in San Diego, California. It raised $66M in Aug 2026, has 29 open roles including a Director, IP Counsel and its filings name 13 officers. Everything below links to the record it came from.
Open roles on the company's own careers page, read nightly.
HiringFiled to go public
CapitalPick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.
Want this matched to what you sell? Get early access to Pursuit Plans →The most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Nov 6, 2026 | 29 open roles, 2 in leadership | Hiring | Careers page |
| Nov 2, 2026 | First legal role posted: Corporate Counsel, Commercial | Hiring | SEC filing |
| Nov 2, 2026 | Hiring a leader: Director, IP Counsel | Hiring | SEC filing |
| Nov 2, 2026 | Posted a Director, IP Counsel opening | Hiring | Careers page |
| Sep 30, 2026 | Posted a Principal / AD / Director, Agentic AI opening | Hiring | Careers page |
| Sep 21, 2026 | Filed to go public | Capital | SEC filing |
| Aug 14, 2026 | Raised $66M in equity from 16 investors | Capital | SEC filing |
| Apr 1, 2026 | Raised $27.8M in equity from 7 investors | Capital | SEC filing |
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Thomas Miller | SEC filing, Aug 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Fred Manby | SEC filing, Aug 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Neil Josephson | SEC filing, Aug 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Michael Secora | SEC filing, Aug 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Pete Olson | SEC filing, Aug 2026 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Jishnu Bhattacharjee | SEC filing, Aug 2026 | Technology and tooling decisions |
| Chief Technology Officer | Evan Rachlin | SEC filing, Aug 2026 | Technology and tooling decisions |
| Chief Technology Officer | R. Jacob Vogelstein | SEC filing, Aug 2026 | Technology and tooling decisions |
| Chief Technology Officer | Mary Tagliaferri | SEC filing, Aug 2026 | Technology and tooling decisions |
| Chief Technology Officer | William Rastetter | SEC filing, Aug 2026 | Technology and tooling decisions |
| Chief Technology Officer | Kurt von Emster | SEC filing, Aug 2026 | Technology and tooling decisions |
| Chief Technology Officer | Shalini Sharp | SEC filing, Aug 2026 | Technology and tooling decisions |
| Chief Technology Officer | Samit Hirawat | SEC filing, Aug 2026 | Technology and tooling decisions |
| Director, IP Counsel | Hiring posted Nov 2, 2026 | Careers page | Technology and tooling decisions |
| Principal / AD / Director, Agentic AI | Hiring posted Sep 30, 2026 | Careers page | Technology and tooling decisions |
| Leadership opening | Hiring posted Nov 2, 2026 | Careers page | First 90 days: tools and vendor review |
Lakewave does the research, the stitching and the first draft with AI, so you spend your time selling.
Lakewave tracks raises, new leaders, hiring and filings across your accounts and territory, and tells you the day something changes.
Find the decision makers, get mailbox-verified addresses and an AI draft written for that account, which you review. Send from your own inbox with open and reply tracking and a follow-up sequence.
Which accounts to pursue, why now, who to reach and what to say, matched to your product and the buyers you sell to.
Every address Lakewave gives you is checked against Iambic Therapeutics's mail server before you see it. Guessed addresses bounce, and bounces are what push a sender's domain toward the spam folder, so one bad list can cost a rep weeks of deliverability. Lakewave shows how each address was confirmed and leaves out the ones it cannot verify.
Use it two ways. Look up the verified address you need for a call you are already planning. Or let Lakewave do the whole job: find the accounts with a reason to buy now, the right people and their addresses, and draft a first email for each person, so you are not stitching together data sources and research by hand.
Try it on Iambic Therapeutics with a free trial →| Headquarters | San Diego, California, per the filing address |
| Industry group | Biotechnology |
| Ownership | Listed company |
| Raise history | $99.3M (Nov 2025) · $27.8M (Apr 2026) · $66M (Aug 2026) |
| Lakewave Rising | 74 · 2 kinds of evidence · rank in California after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Iambic Therapeutics reported a $66M equity raise to the SEC on Aug 14, 2026 with 16 investors.
The company's SEC filing, Aug 2026 names Thomas Miller (Executive Officer) among its officers.
Yes. 29 roles were open on its careers page on Nov 10, 2026, including a Director, IP Counsel posted Nov 2, 2026.
San Diego, California, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialEvery account you select comes back scored by what changed this month, with the source for each fact.
Named officers from filings and announcements, each with an address verified against the mailbox. No bounces, no guessed patterns, no scraped profiles.
Lakewave writes a first email for each person, tailored to their role and company. You edit, approve and send it from your own mailbox.
A weekly note on what changed across your targets, so no account moves without you knowing.
Free trial · No credit card · Built from public records, refreshed nightly
Compiled from public records and refreshed nightly; last updated Nov 10, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.